Armata Pharmaceuticals (ARMP) Prepaid Assets (2013 - 2026)
Armata Pharmaceuticals' (ARMP) quarterly Prepaid Assets came in at $47000.0 in Q1 2026, down 96.21% year-on-year from $1.2 million in Q1 2025, and down 96.88% quarter-over-quarter from $1.5 million in Q4 2025.
Armata Pharmaceuticals (ARMP) Prepaid Assets (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has disclosed Prepaid Assets across 14 years of filings, most recently posting $47000.0 for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $47000.0, down 96.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $47000.0 (down 96.21% YoY), and the FY2025 annual result was $1.5 million, up 18.46% from the prior year.
- Prepaid Assets came in at $47000.0 for Q1 2026 at Armata Pharmaceuticals, down from $1.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $12.2 million in Q1 2023 to a low of $47000.0 in Q1 2026.
- The 5-year median for Prepaid Assets is $2.4 million (2022), against an average of $3.4 million.
- Across the five-year window, Prepaid Assets jumped 1059.43% in 2023 and sank 96.21% in 2026, its largest moves.
- Armata Pharmaceuticals' Prepaid Assets stood at $3.7 million in 2022, then decreased by 8.22% to $3.4 million in 2023, then sank by 62.15% to $1.3 million in 2024, then rose by 18.46% to $1.5 million in 2025, then plunged by 96.88% to $47000.0 in 2026.
- The last three Prepaid Assets figures came in at $47000.0 (Q1 2026), $1.5 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 3.26 Mn |
| Mar 31, 2024 | 2.14 Mn |
| Dec 31, 2023 | 3.36 Mn |
| Sep 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Mar 31, 2023 | 12.23 Mn |
| Dec 31, 2022 | 3.66 Mn |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 1.72 Mn |
| Sep 30, 2021 | 851,000.00 |
| Jun 30, 2021 | 1.01 Mn |